Blood circulation of soft nanomaterials is governed by dynamic remodeling of protein opsonins at nano-biointerface

[1]  B. Snyder,et al.  Mega macromolecules as single molecule lubricants for hard and soft surfaces , 2020, Nature Communications.

[2]  Srinivas Abbina,et al.  Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron , 2019, ACS central science.

[3]  K. Landfester,et al.  Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins. , 2018, Acta biomaterialia.

[4]  Jong-Min Lim,et al.  Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.

[5]  Seyed Moein Moghimi,et al.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. , 2017, Nature nanotechnology.

[6]  G. Caracciolo,et al.  In vivo protein corona patterns of lipid nanoparticles , 2017 .

[7]  Kannan M. Krishnan,et al.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. , 2015, Chemical Society reviews.

[8]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[9]  S. Stolte,et al.  The nanoparticle biomolecule corona: lessons learned - challenge accepted? , 2015, Chemical Society reviews.

[10]  Marilena Hadjidemetriou,et al.  In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. , 2015, ACS nano.

[11]  E. Conway,et al.  Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. , 2014, ACS nano.

[12]  Marco Y. Hein,et al.  Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.

[13]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[14]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[15]  D. Brooks,et al.  Solvent‐assisted anionic ring opening polymerization of glycidol: Toward medium and high molecular weight hyperbranched polyglycerols , 2013 .

[16]  Yaping Li,et al.  Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.

[17]  Bing Wang,et al.  Metabolism of nanomaterials in vivo: blood circulation and organ clearance. , 2013, Accounts of chemical research.

[18]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[19]  J. Kizhakkedathu,et al.  Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution. , 2012, Biomaterials.

[20]  Lei Zhang,et al.  Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. , 2012, ACS nano.

[21]  Warren C W Chan,et al.  Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.

[22]  Albert Duschl,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[23]  L. Foster,et al.  Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products , 2010, Nature Biotechnology.

[24]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[25]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[26]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[27]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[28]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[29]  Souvik Maiti,et al.  Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. , 2006, Biomaterials.

[30]  Francis C Szoka,et al.  Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2005, Molecular pharmaceutics.

[31]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[32]  M. Mann,et al.  Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mann,et al.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.

[34]  Elizabeth R Gillies,et al.  Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2002, Journal of the American Chemical Society.

[35]  Y. Sugiyama,et al.  Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[36]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[37]  L. Perlemuter.  [From theory to practice]. , 1997, Soins. Psychiatrie.